Nitric oxide and prostacyclin pathways: An integrated mechanism that limits myocardial infarction progression in anaesthetized rats

Pharmacological Research

Volumn 53, Issue 4, 2006, Pages 359-366

  Rossoni, Giuseppe ^a   Manfredi, Barbara ^a   De Gennaro Colonna, Vito ^a   Brini, Anna Teresa ^a   Polvani, Gianluca ^a   Clement, Maria Giovanna ^a   Berti, Ferruccio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cardioprotection; Ischemia reperfusion; Myocardial infarction; Nitric oxide; Prostacyclin

Indexed keywords

ARGININE; CREATINE KINASE; DEFIBROTIDE; ISOSORBIDE DINITRATE; MYELOPEROXIDASE; NAPROXEN; NITRATE; NITRIC OXIDE; NITRITE; NITRONAPROXEN; PROSTACYCLIN; THROMBOXANE B2;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BRAIN INFARCTION SIZE; CARDIOVASCULAR PARAMETERS; CIRCULATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; EVALUATION; HEART INFARCTION; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE WALL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; INHIBITION KINETICS; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RECORDING; SURVIVAL RATE;

ANIMALS; ARGININE; ARRHYTHMIA; CARDIOTONIC AGENTS; CREATINE KINASE; EPOPROSTENOL; ISOSORBIDE DINITRATE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; NAPROXEN; NITRIC OXIDE; PEROXIDASE; POLYDEOXYRIBONUCLEOTIDES; RANDOM ALLOCATION; RATS; RATS, WISTAR; THROMBOXANE B2;

EID: 33645959518     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.01.004     Document Type: Article

References (49)

1. Ryan T.J., Antman E.M., Brooks N.H., Califf R.M., Hillis L.D., Hiratzka L.F., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 34 (1999) 890-911
2. Jugdutt B.I. Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev 7 (2002) 391-405
3. Litt M.R., Jeremy R.W., Weisman H.F., Winkelstein J.A., and Becker L.C. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 min of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation 80 (1989) 1816-1827
4. Granger D.N., Benoit J.N., Suzuki M., and Grisham M.B. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol 257 (1989) G683-G688
5. Tsao P.S., Ma X.L., and Lefer A.M. Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J 123 (1992) 1464-1471
6. Ellis S.G., Topol E.J., Gallison L., Grines C.L., Langburd A.B., Bates E.R., et al. Predictors of success for coronary angioplasty performed for acute myocardial infarction. J Am Coll Cardiol 12 (1988) 1407-1415
7. Jugdutt B.I. Nitroglycerin. In: Bates E. (Ed). Thrombolysis and adjunctive therapy for myocardial infarction (1992), Dekker, New York 119-144
8. Wallace J.L., and Granger D.N. The cellular and molecular basis of gastric mucosal defense. FASEB J 10 (1996) 731-740
9. Rossoni G., Berti M., De Gennaro Colonna V., Bernareggi M., Del Soldato P., and Berti F. Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit. Ital Heart J 1 (2000) 146-155
10. Rossoni G., Manfredi B., De Gennaro Colonna V., Bernareggi M., and Berti F. The nitroderivative of aspirin, NCX 4016, reduces infarct size caused by myocardial ischemia-reperfusion in the anaesthetized rat. J Pharmacol Exp Ther 297 (2001) 380-387
11. Rossoni G., Manfredi B., Del Soldato P., and Berti F. The nitric oxide-releasing naproxen derivative displays cardioprotection in perfused rabbit heart submitted to ischemia-reperfusion. J Pharmacol Exp Ther 310 (2004) 555-562
12. Shepherd J.T., and Katusic Z.S. Endothelium-derived vasoactive factors: I. Endothelium-dependent relaxation. Hypertension 18 (1991) III76-III85
13. Osanai T., Fujita N., Fujiwara N., Nakano T., Takahashi K., Guan W., et al. Cross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells. Am J Physiol Heart Circ Physiol 278 (2000) H233-H238
14. Veeravalli K.K., and Akula A. Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction. Pharmacol Res 1 (2004) 23-29
15. Vanhoutte P.M. Endothelium-dependent hyperpolazitation: the history. Pharmacol Res 49 (2004) 503-508
16. Parkington H.C., Coleman H.A., and Tare M. Prostacyclin and endothelium-dependent hyperpolazitation. Pharmacol Res 49 (2004) 509-514
17. de Wit C., Bolz S.S., and Pohl U. Interaction of endothelial autacoids in microvascular control. Z Kardiol 89 (2000) 113-116
18. Raghavan S.A., and Dikshit M. Vascular regulation by the l-arginine metabolites, nitric oxide and agmatine. Pharmacol Res 49 (2004) 397-414
19. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90 (1993) 7240-7244
20. Himori N., and Matsuura A. A simple technique for occlusion and reperfusion of coronary artery in conscious rats. Am J Physiol 256 (1989) H1719-H1725
21. Baller D., Bretschneider H.J., and Hellige G. A critical look at currently used indices of myocardial oxygen consumption. Basic Res Cardiol 76 (1981) 163-181
22. Clark C., Foreman M.I., Kane K.A., McDonald F.M., and Parratt J.R. Coronary artery ligation in anaesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Meth 3 (1980) 357-368
23. Walker M.J.A., Curtis M.J., Hearse D.J., Campbell R.W.F., Janse M.J., Yellon D.M., et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 22 (1988) 447-455
24. Klein H.H., Puschmann S., Schaper J., and Schaper W. The mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. Arch Pathol Anat 393 (1981) 287-297
25. Mullane K.M., Kraemer M.R., and Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Meth 14 (1985) 156-167
26. Schierwagen C., Bylund-Fellenius A.C., and Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Meth 23 (1990) 179-186
27. Rosalki S.B. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 69 (1967) 696-705
28. th Edition. (1989), Iowa State University Press, Ames, IA
29. Schulz R., Kelm M., and Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 61 (2004) 402-413
30. Kelm M. Nitric oxide metabolism and breakdown. Biochim Biophys Acta 1411 (1999) 273-289
31. Salvemini D., Currie M.G., and Mollace V. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. J Clin Invest 97 (1996) 2562-2568
32. Vassalle C., Domenici C., Lubrano V., and L'Abbate A. Interaction between nitric oxide and cyclooxygenase pathways in endothelial cells. J Vasc Res 40 (2003) 491-499
33. Lefer A.M., and Lefer D.J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 32 (1996) 743-751
34. Jordan J.E., Zhao Z.Q., and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43 (1999) 860-878
35. Bruckdorfer R. The basics about nitric oxide. Mol Aspects Med 26 (2005) 3-31
36. Rossoni G., Sala A., Buccellati C., Maclouf J., Folco G.C., and Berti F. Vasoconstriction to polymorphonuclear leukocytes in the isolated, perfused rabbit heart: inhibition by prostacyclin mimetics. J Cardiovasc Pharmacol 27 (1996) 680-685
37. 4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science 217 (1982) 841-843
38. Sala A., Rossoni G., Buccellati C., Berti F., Folco G., and Maclouf J. Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit. Br J Pharmacol 110 (1993) 1206-1212
39. Grisham M.B., Granger D.N., and Lefer D.J. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med 25 (1998) 404-433
40. Vinten-Johansen J., Zhao Z.Q., Nakamura M., Jordan J.E., Ronson R.S., Thourani V.H., et al. Nitric oxide and the vascular endothelium in myocardial ischemia-reperfusion injury. Ann NY Acad Sci 874 (1999) 354-370
41. Ronson R.S., Nakamura M., and Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res 44 (1999) 47-59
42. Parlakpinar H., Ozer M.K., and Acet A. Effect of aminoguanidine on ischemia-reperfusion induced myocardial injury in rats. Mol Cell Biochem 277 (2005) 137-142
43. Sahna E., Parlakpinar H., Cihan O.F., Turkoz Y., and Acet A. Effects of aminoguanidine against renal ischaemia-reperfusion injury in rats. Cell Biochem Funct 24 (2004) 137-141
44. Patel V.C., Yellon D.M., Singh K.J., Neild G.H., and Woolfson R.G. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem Biophys Res Commun 194 (1993) 234-238
45. Woolfson R.G., Patel V.C., Neild G.H., and Yellon D.M. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91 (1995) 1545-1551
46. Siegfried M.R., Erhardt J., Rider T., Ma X.L., and Lefer A.M. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 260 (1992) 668-675
47. Sato H., Zhao Z.Q., McGee D.S., Williams M.W., Hammon J.W., and Vinten-Johansen J. Supplemental l-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg 110 (1995) 302-314
48. Garcia Rodriguez L.A., and Gonzalez-Perez A. Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC Med 3 (2005) 17
49. Capone M.L., Sciulli M.G., Tacconelli S., Grana M., Ricciotti E., Renda G., et al. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. J Am Coll Cardiol 45 (2005) 1295-1301